Stereoselective Synthesis of 1,6,9-Tri-oxaspiro[4.5]decanes From d -Glucose: Novel Structural Motifs of Spiroacetal Natural Products

Abstract

Spiroacetals are the central structural core element of numerous natural products and are essential for their biological activity. A typical structural representative of a spiroacetal is the bicyclic 1,6-dioxaspiro[4.5]decane ring system. It represents the complete or partial structure of many biologically potent natural products such as the Paravespula pheromone 1, the antibiotic (+)-monensin A 2, the anticancer agent (−)-berkelic acid 3, the antimitotic ingredient spirastrellolide F, characterized after methylation as (+)-methyl ester 4, and the marine toxin (−)-calyculin A 5. In these compounds, the 1,6-dioxaspiro[4.5]decane ring system is found in either spiro (R)-6 or (S)- 6 configuration. The corresponding 1,6,9-trioxaspiro[4.5]decane framework (S)-7 and (R)-7 with opposite chirality at the spiro center due to an additional oxygen atom at position 9 in the pyran portion has so far not been found in living organisms or been synthesized. To close this gap and enable structure–activity relationship studies, potentially leading to novel antibiotics and selective anticancer agents, we have developed an efficient and stereocontrolled route to the (R)- and (S)-configurated 1,6,9-trioxaspiro[4.5]decane ring system leading to oxa analog motifs of the above natural products.

Keywords

spiroacetal bioactivity pheromone antibiotic marine toxin

Spiroacetals are the central structural core element in a multitude of natural products of insect, marine, bacterial, or plant origin.^1

-6 A typical example of an organism producing a spiroacetal compound is the wasp Paravespula vulgaris, a social insect constructing and living in communal nests. The wasps emit an aggregation pheromone with spiroacetal molecular structure (Figure 1) for the purpose of mating and overwhelming predators.

Figure 1

(a) The wasp Paravespula vulgaris taking water on duckweed Lemna minor. (b) Paravespula nest attached to a concrete ceiling and superimposed in yellow the species-specific spiroacetal molecular structure of the aggregation pheromone produced by these insects. Photos were taken by the author in his garden and garage, summer 2019, Seeheim, Germany.

This aggregation pheromone is the minor bouquet component and a mixture of 2 diasteriomers of 2-methyl-1,6-dioxaspiro[4.5]-decane with either cis or trans geometry in the furan ring of the methyl group and the pyran oxygen atom⁷ (1 in Figure 2). The absolute stereochemistry with regard to the biological activity is still unknown, although all 4 possible stereoisomers have been synthesized.^8

-14 More complex structures with bicyclic 1,6-dioxaspiro[4.5]decane ring system and spiro (R)- as well as spiro (S)-configuration are found in the following natural products: (1) (+)-monensin A 2, a polyether ionophorous antibiotic and formed as a metabolite in a biosynthesis of Streptomyces cinnamonensis bacteria^15

-18; (2) (−)-berkelic acid 3, a novel spiroketal and unique secondary metabolite with selective anticancer activity isolated from an extremophilic Penicillium species^19

-25; (3) spirastrellolide F, a potent antimitotic agent of the marine sponge Spirastrella coccinea, whose structure has been characterized after methylation as (+)-methyl ester 4 ^26

-30; and (4) (−)-calyculin A 5, a toxin blocking calcium influx and inhibiting protein Ser/Thr phosphatase isolated from the marine sponge Discodermia calyx.^31

-34

Figure 2

Typical spiroketal natural products with 1,6-dioxaspiro[4.5]decane structural motif (highlighted in red): Paravespula pheromone 1, (+)-monensin A 2, (−)-berkelic acid 3, (+)-spirastrellolide F methyl ester 4, and (−)-calyculin A 5. Whilst the 1,6-dioxaspiro[4.5]decane motifs (R)-6 and (S)-6 are essential for biological activity, their oxa analogs (S)-7 and (R)-7, with opposite chirality at the spiro center, are not found in nature. Interestingly, both (R)- 6 and (S)- 6 are realized in the molecular structure of di-d-fructose anhydride I 8.

Biological studies disclosed that the spiroacetal framework is essential for biological activity in these types of natural compounds.^35

-40 Given their diverse biological activity, Zinzalla et al⁴¹ designed and synthesized spiroketal derivatives, leading to a collection of new small molecules for biological evaluation as orally bioavailable lead compounds. The use of spirocyclic scaffolds in drug discovery has been reviewed.⁴² With regard to drug design, in 2017, Scheepstra et al⁴³ published a paper entitled ”Designed Spiroketal Protein Modulation”, describing that spiroketals are arguably well-suited for 2 approaches: (1) diversity-oriented synthesis and (2) biology-oriented synthesis.

The 1,6-dioxaspiro[4.5]decane ring system is found in nature with either spiro (R)- or spiro (S)-configuration (structures (R)- 6 and (S)- 6 marked in red in Figure 2). The corresponding 1,6,9-trioxaspiro[4.5]decane framework (S)-7 and (R)-7 with opposite chirality at the spiro center, due to the additional oxygen atom in the dioxane portion (oxygen marked in blue), has not yet been found in nature. To close this gap and enable the characterization of these compounds in view of structure–activity relationship studies, we here describe an efficient and stereocontrolled route to derivatives with (R)- as well as (S)-configurated 1,6,9-trioxaspiro[4.5]decane ring system. These novel compounds contain the oxa analog motifs of the aforementioned natural products depicted in Figure 2.

Syntheses

The chemical elaboration of the 1,6,9-trioxaspiro[4.5]decane ring system is difficult and only a few racemic approaches are known. These include the electrolysis of mono furfuryl ethers,^44,45 a carbon–carbon bond formation reaction of a diazoketone⁴⁶ and the selective reduction of analogs of the secondary metabolite and antifeedant tonghaosu.^47,48 A newer US patent⁴⁹ describes the cyclization of keto diols with 1 stereogenic center, which yields derivatives of 1, but with unspecified stereochemistry at the spiro center and in the dioxane portion. The 1,6,9-trioxaspiro[4.5]decanes described are potentially useful for the diagnosis and treatment of diseases of cell membrane lipid asymmetry. Interestingly, the reaction of anhydrous hydrogen fluoride with d-fructose, sucrose, or inulin leads among others to di-d-fructose anhydride I 8, a tricyclic molecule with 2 1,6,9-trioxaspiro[4.5]decane ring systems.^50,51

In the early 1980s, we developed a practical method for the conversion of the 2 literature-known d-glucose-derived 2-hydroxyglycal esters 9a ^52,53 and 9b ⁵⁴ into the corresponding ulosyl bromides 10a ^55,56 and 10b.⁵⁷ We subsequently published⁵⁸ the glycosylation of 10a with the diol ethylene glycol to the bicyclic pyranodioxane (1,4,5-trioxa-cis-decaline) 11a. In the same paper, we also reported the ring contraction of 11a to the 2 1,6,9-tri-oxaspiro[4.5]decanes 14a and 15a together with consecutive bromide 16a and its dehalogenated derivative 17a.

Here we describe for the first time the glycosylation of the 6-deoxyulosyl bromide 10b with ethylene glycol to the β-cis-annulated bicyclic pyranodioxane 11b. Its further spiroacetalization by adopting our synthetic strategy leads to novel 1,6,9-tri-oxaspiro[4.5]decane derivatives possessing a methyl instead of a benzoyloxymethyl group in the 5-membered furan moiety. Consequently, their structure is more closely related to the naturally occurring spiroacetal motifs. Furthermore, the structural elucidation of all new and known 1,6,9-tri-oxaspiro[4.5]decane derivatives is discussed and presented.

Derivatives with Spiroacetal Motif (R)-7

The stereoselective synthesis of compounds with the spiroacetal motif (R)-7 (1,6,9-tri-oxaspiro[4.5]decane-structure) from d-glucose is shown in Scheme 1.

Scheme 1

Conversion of the d-glucose-derived ulosyl bromides 10 into the bicyclic pyranodioxanes 11 furnished by acid-catalyzed ring contraction and acylation (via protonated 11, oxonium cation 12 and (10R)-13) the 1,6,9-tri-oxaspiro[4.5]decane derivatives 14a⁵⁸ and 15a⁵⁸ as well as 14b and 15b. Their bromination (through intermediates 16a,⁵⁸ 16b) and successive dehalogenation gave the 2 Paravespula pheromone derivatives 17a⁵⁸ and 17b. Further reaction of 16a with different alcohols afforded the spiroketal glycosides 18, 19, 20, and 21, which are lead structures for drug design.

The reaction of the 6-deoxy-ulosyl bromide 10b with ethylene glycol in dichloromethane in the presence of silver carbonate (Koenigs–Knorr conditions) gave the 6-deoxy-pyranodioxane 11b as colorless crystals in 95% yield. Under these reaction conditions, only β-glycosylation took place (C-1 attack), which is immediately followed by ketalization through β-attack at C-2. Further reaction of 11b with acetic acid anhydride or benzoic acid anhydride in the presence of perchloric acid (70%) gave, after protonation in an equilibrium reaction, 12, which undergoes ring contraction to (10R)-13, as shown by the arrows. The hydroxyl group of (10R)-13 was immediately trapped by acylation to afford the spiro[4.5]ketals 14b and 15b in 94% and 77% yield, respectively (see Scheme 1). The esterification of the OH-group occurred under these equilibrium conditions because the secondary hydroxy group is much more reactive than the comparatively unreactive tertiary OH-group of the starting material, the pyranodioxane (1,4,5-trioxa-cis-decaline) 11b. The stereospecific ring contraction is especially notable because other diastereomers were not detectable (thin-layer chromatography [TLC], nuclear magnetic resonance [NMR]).

As shown by a comparison experiment, no appreciable conversion occurred by the reaction of 11a with perchloric acid (70%) in dichloromethane and the absence of an acylating agent at room temperature. At reflux temperature (40°C), a continuous conversion arose and after 2 hours, a 1:3 equilibrium mixture of 11a and (10R,S)-13a has been achieved. The mixture of (10R,S)-13 was also obtained by hydrolysis of 16a (see the section Experimental).

Subsequent bromination of 15b gave 16b, which could be radically dehalogenated to 17b. Reaction of 16a with methanol, isopropanol, cyclohexanol and cholesterol afforded under Koenigs–Knorr conditions the corresponding glycosides 18, 19, 20, and 21, all in over 86% yield. No side products were formed because a stereospecific S_N2-attack is guaranteed under these reaction conditions with silver carbonate as acid scavenger (see Scheme 1).

The synthesized compounds possess the (5R)-1,6,9-tri-oxaspiro[4.5]decane framework (R)-7, which corresponds to structure (S)-6, the spiroacetal motif found in (−)-berkelic acid 3, (+)-spirastrellolide F methyl ester 4, and (−)-calyculin A 5. They resemble those motifs even more, because of the newly implemented methyl group. In particular, the spiroacetal 17b represents an oxo derivative of the Paravespula pheromone 1.

Derivative with Spiroacetal Motif (S)-7

The stereospecific conversion of the pyranodioxane 22 to a derivative with framework (S)- 7 could also be achieved.⁵⁸ But in contrast to its (R)-configurated counterpart, the yield was lower and the reaction process less homogenous. For that reason, we also studied this stereoselective ring contraction of 22.

The pyranodioxane 22 is obtainable from ulosyl bromide 10a and ethylene glycol in dimethylformamide.⁵⁸ Further reaction with benzoic acid anhydride and perchloric acid (70%) gave via protonation (through intermediate 23) and rearrangement (through intermediate 24) spiro compound 25 in 61% yield. A more detailed examination of the reaction revealed that the open-chain side product 26 was formed as well (30%). The reason for its formation is the reduced stability of the pyranodioxane 22, compared with its isomer 11a under these acidic reaction conditions. Thus, the ketal function of 22 at C-2 is split off and the resulting open-chain form was immediately benzoylated to the glycoside 26 (Scheme 2).

Scheme 2

The examination of the acid catalyzed ring contraction of the pyranodioxane 22 revealed that in the presence of benzoic acid anhydride, not only the required 25 was formed but also the undesired open-chain side product 26. Protonated starting material 22 and structures 23 and 24 are intermediates on the reaction path to 25. The starting material 22 is readily obtainable from d-glucose-derived ulosyl bromide 10a.⁵⁸

The synthesized 1,6,9-tri-oxaspiro[4.5]decane derivative 25 contains the framework (S)-7, which corresponds to the structure (R)-6, the spiroacetal motif of (+)-monensin A 2.

Structural Elucidation

The configuration and conformation of the aforementioned 1,6,9-tri-oxaspiro[4.5]decanes with either (R)- or (S)-spiro framework could be resolved on the basis of ¹H and ¹³C NMR data.

Furan Portion

The relevant proton chemical shifts and coupling constants of the ring protons in the tetrahydrofuran portion are listed in Table 1.

Table 1

Selected Proton Chemical Shifts and ¹H-¹H Coupling Constants of 1,6,9-Trioxaspiro[4.5]decanes in the Tetrahydrofuran Portion (300 MHz in CDCl₃, δ in ppm, J in Hz)^a.


Comp.	X	2H	3H	4H	J _2,3	J _3,4
(A) Spiroacetal motif (R)-7 and X axial
14a ⁵⁸	OAc	4.59	5.91	5.91	n.d.^b	n.d.^b
15a ⁵⁸	OBz	4.63	5.94	6.02	5.5	7.1
16a ⁵⁸	Br	4.59	5.79	5.89	5.4	6.5
14b	OAc	4.34	5.56	5.83	5.2	6.8
15b	OBz	4.37	5.58	5.89	5.2	6.8
16b	Br	4.33^c	5.42	5.81	5.0	5.9
(B) Spiroacetal motif (R)-7 and X equatorial
18	OMe	4.64	6.02	5.91	5.2	6.8
19	OiPr	4.66	5.97	5.84	5.1	6.0
20	OC₆H₁₁	4.69	5.97	5.85	5.1	5.6
21	OChol	4.70	5.93	5.82	4.3	5.4
(C) Spiroacetal motif (S)-7 and X axial
25 ⁵⁸	OBz	4.62	5.51	5.76	4.4	0.4

^aThe complete data are listed in the Experimental Part and in Cuny et al.⁵⁸

^bn. d. indicates not determined, due to the overlap of the shifts of 3H and 4H

^cOverlap with the shift of 7H_a.

The chemical shifts for 2H, 3H, and 4H of compounds with the spiroacetal motif (R)-7 are as expected of the same order of magnitude in each case of (A) and (B) in Table 1. In contrast to this, the ring proton 3H of 25 with framework (S)-7 (C in Table 1) has a pronounced high field shift of 0.43 ppm, as compared to its corresponding (R)-7 counterpart, the compound 15a. This distinctive difference is caused by the lack of 1,3-diaxial interaction of the furan 3H with the dioxane oxygen O-6 in 25, a finding, that could be used to determine the configuration of the spiro center in these kinds of spiroacetals with 1,6,9-tri-oxaspiro[4.5]decane ring system.

The same result was also found by Lemieux and Nagarajan⁵⁹ in the hexaacetate of di-d-fructose anhydride I (1-(α-d-fructofuranosyl)-β-d-fructofuranose) 27. Furthermore, the structure of 27 is particularly well suited for an extensive structural study, because both motifs (R)- 7 and (S)- 7 are realized in this molecule (see Figure 3). In this context, the coupling constants J _2,3 and J _3,4 of the 1,6,9-tri-oxaspiro[4.5]decane derivatives in Table 1 correspond to J _4,5, J _4′,5′ and J _3,4, J _3′,4′ of 27. The values of the coupling constants demonstrate also that the compounds 14–21 with framework (R)- 7 possess a ( ⁵E)-envelope conformation in solution, whilst this is ( ^OE) in the (S)- 7-representative 25.

Figure 3

Molecular geometry and ¹H-¹H coupling constants of the hexaacetate of di-d-fructose anhydride I (1-(α-d-fructofuranosyl)-β-d-fructofuranose) 27 with carbohydrate numbering as published by Lemieux and Nagarajan.⁵⁹ For a better understanding, the underlying 1,6,9-trioxaspiro[4.5]decane motifs (R)-7 and (S)- 7, with chair conformation and IUPAC numbering, are also given.

1,4-Dioxane Portion

The chemical shifts of the ring protons in the dioxane portion are listed in Table 2. Their axial/equatorial orientation could be easily distinguished by the width of their chemical shifts.

Table 2

Selected Proton Chemical Shifts of 1,6,9-Trioxaspiro[4.5]decanes in the 1,4-Dioxane Portion with Either (R)- or (S)-Configuration (300 MHz in CDCl₃, δ in ppm)^a.


Comp.	X	7H_a	7H_e	8H_a	8H_e	10H
(A) Spiroacetal motif (R)- 7 and X axial
14a ⁵⁸	OAc	4.12	3.55	4.46	3.67	5.99
15a ⁵⁸	OBz	4.23	3.61	4.49	3.75	6.23
16a ⁵⁸	Br	4.30	3.67	4.45	3.76	6.28
14b	OAc	4.14	3.59	4.46	3.74	5.93
15b	OBz	4.24	3.64	4.54	3.81	6.20
16b	Br	4.33^b	3.70	4.50	3.83	6.23
(B) Spiroacetal motif (R)- 7 and X equatorial
18	OMe	4.19	3.46	3.82	3.88	4.64
19	OiPr	4.18	3.46	3.83	3.83	4.81
20	OC₆H₁₁	4.19	3.46	3.83	3.83	4.89
21	OChol	4.17	3.45	3,83	3.83	4.86
(C) Spiroacetal motif (S)- 7 and X axial
25 ⁵⁸	OBz	4.27	3.69	4.45	3.78	6.38

^aThe multiplicity of the shifts and the coupling constants are listed in the section Experimental and in Cuny et al.⁵⁸

^bOverlap with the shifts of 2H.

Due to the large geminal and axial coupling constants, 7H_a and 8H_a possess broad ddd-shifts whereas 7H_e and 8H_e are characterized by narrow pdd-shifts, because only one large geminal coupling constant is found.

7H_a and 8H_a could be further differentiated on the basis of the strong downfield shift for 8H_a (4.45–4.54 ppm vs 4.12–4.33 for 7H_a) in compounds with an axial substituent at C-10 (A and C in Table 2). Responsible for this extensive effect is the 1,3-diaxial interaction of the electronegative substituent X at C-10 with 8H_a.

The determination of 8H_a in compounds possessing an equatorial substituent X at C-10 was substantiated by the observed NOE interactions of 10 H → 8 H_a (B in Table 2).

Due to the relatively long distance of 5 bonds to the substituent at C-10, the values of the chemical shift for the 2 geminal protons 7H_a (4.12-4.33 ppm) and 7H_e (3.45-3.70 ppm) are approximately of the same magnitude in all cases (A, B, and C in Table 2). The same result is obtained for 8H_e (3.67-3.88 ppm) possessing a distance of 4 bonds.

¹³C NMR Spectral Data

The ¹³C NMR spectral data of the synthesized 1,6,9-trioxaspiro[4.5]decanes are listed in Table 3. For each of these compounds, the values of the chemical shifts correlate well. As expected, notable differences are found for the carbon atom C-10, because it possesses different substituents. Thus, the values for the chemical shifts for 14a, 14b, 15a, 15b, 25 (R = OAcyl) are around δ = 89 ppm, for 16a, 16b (R = Br) around δ = 87 ppm and for 18, 19, 20, 21 (R = Oalkyl) around δ = 98 ppm. The axial or equatorial orientation of the substituent at C-10 could also be determined from the chemical shift of the dioxane carbon C-8. Compounds with an axial orientation (A and C) possess values around 60 ppm, whereas their equatorial counterparts (C) have all the same values of 65.2 ppm.

Table 3

Selected ¹³C Nuclear Magnetic Resonance Data^a of 1,6,9-Trioxaspiro[4.5]decanes (75.5 MHz in CDCl₃, δ in ppm).


Comp.	C-2	C-3	C-4	C-5	C-7	C-8	C-10	C-2′
(A) Spiroacetal motif (R)-7 and X axial
14a ⁵⁸	79.0	77.1	75.5	98.6	59.1	60.0	89.5	65.1
15a ⁵⁸	79.1	77.1	75.5	99.1	59.4	60.1	89.9	65.2
16a	78.7	77.1	76.6	99.3	60.2	60.4	86.3	64.8
14b	78.2	81.7	76.0	98.7	59.8	59.3	89.6	21.3
15b	78.3	81.9	76.0	99.0	59.5	60.0	90.1	21.3
16b	78.6	82.2	77.5	100.2	60.7	60.0	87.1	21.1
(B) Spiroacetal motif (R)-7 and X equatorial
18	79.3	76.7	76.2	100.9	60.2	65.2	99.4	64.9
19	79.4	77.4	76.6	101.3	60.3	65.2	97.6	64.7
20	81.1	76.7	77.5	101.3	60.3	65.2	97.2	64.6
21	79.6	77.6	76.6	101.4	60.3	65.2	97.4	64.6
(C) Spiroacetal motif (S)-7 and X axial
25 ⁵⁸	82.1	78.6	81.1	102.8	59.6	59.5	88.2	63.5

^aThe complete data are listed in the section Experimental and in Cuny et al.⁵⁸

Concluding Remarks

The 1,6-dioxaspiro[4.5]decane motifs (R)-6 and (S)-6 are essential for biological activity and found in nature in the aggregation pheromone 1, the antibiotic (+)-monensin A 2, the anticancer substance (−)-berkelic acid 3, the antimitotic agent spirastrellolide F (characterized after methylation as (+)-methyl ester 4), and the toxin (−)-calyculin A 5. We developed an efficient and stereocontrolled preparation of oxo analogs of these motifs with either (R)- or (S)-configuration and 1,6,9-tri-oxaspiro[4.5]decane framework.⁵⁸ In view of structure–activity relationship studies, here we describe additional spiroacetals that resemble the natural products even more than previously published spiroacetal structures. These novel compounds possess a methyl instead of a benzoyloxymethyl group in the 5-membered furan moiety.

The 6-deoxy-pyranodioxane 11b was obtained in 95% yield by starting from the d-glucose derived 6-deoxy-ulosyl bromide 10b and ethylene glycol. Further reaction with acetic acid anhydride or benzoic acid anhydride in the presence of perchloric acid (70%) gave the spiro[4.5]ketals 14b and 15b in 94% and 77% yield, respectively. Diastereomers were not detectable, showing that the ring contraction takes place in a stereospecific manner. Subsequent bromination of 15b yielded the halide 16b, which could be radically dehalogenated to 17b. Glycosylation of 16a with methanol, isopropanol, cyclohexanol, and cholesterol afforded the corresponding derivatives 18, 19, 20, and 21, each in over 86% yield.

The synthesized compounds possess the (5R)-1,6,9-tri-oxaspiro[4.5]decane framework (R)-7, which corresponds to structure (S)-6, the spiroacetal motif of (−)-berkelic acid 3, (+)-spirastrellolide F methyl ester 4, (−)-calyculin A 5, and in particular, the Paravespula pheromone 1.

The synthesis of (5S)-1,6,9-trioxaspiro[4.5]decanes with opposite chirality is also possible.⁵⁸ To further clarify the reaction process, we studied the formation of the (5S)-1,6,9-trioxaspiro[4.5]decane 25, too. The reaction of the pyranodioxane 22 with benzoic acid anhydride in the presence of perchloric acid revealed that apart from 25 (in 61% yield) the open-chain side product 26 was also formed (30%). Responsible for the generation of 26 is the low stability of the starting acetal 22 in the acidic reaction media. Both compounds, 25 and 26, could be characterized after separation. The key product, the (5S)-1,6,9-tri-oxaspiro[4.5]decane 25, possesses the spiroacetal motif of the oxo analogs of the antibiotic (+)-monensin A 2.

The ¹H and ¹³C NMR data of 1,6,9-tri-oxaspiro[4.5]decanes that are published and described herein are summarized in Tables 1 -3. On the basis of these data, together with an X-ray analysis of compound 15a,⁵⁸ their configuration and conformation could be resolved. The chemical shifts of the above spiroacetals are of the same order of magnitude for the appropriate ring protons in the tetrahydrofuran portion. Only 3H of the (5S)-diastereomer 25 has a pronounced high-field shift of 0.43 ppm (see Table 1). This effect is caused by the loss of the 1,3-diaxial interaction of 3H with the dioxane oxygen O-6. The observed coupling constants of all 1,6,9-tri-oxaspiro[4.5]decane derivatives (see Table 1) correlate well with those of the hexaacetate of di-d-fructose anhydride I 27. In this molecule, both the (5R)- as well as the (5S)-1,6,9-tri-oxaspiro[4.5]decane entity are realized. In 27 and the other structures described here the configurations of the furan portion are identical. These are a ( ⁵E)-envelope conformation for all (5R)-configurated compounds 15-21 and a ( ^OE)-envelope conformation for the (5S) representative 25.

The axial or equatorial arrangement of the substituent at C-10 could be established from the chemical shift value of the 8H_a dioxane proton, which is 4.45-4.50 ppm for an axial arrangement and 3.82-3.84 ppm for an equatorial configuration (see Table 2). The influence of the C-10 substituent on the values of the chemical shifts of the tetrahydrofuran ring protons is not significant because it is relatively far away.

The synthesized 1,6,9-tri-oxaspiro[4.5]decane motifs 14b, 15b, 16b, 17b, 18, 19, 20, and 21 are new and unique, and their altered chemical properties make them promising lead structures for pharmacological evaluation. Bioactivity and cytotoxicity tests would be logical first steps toward uncovering the pharmacological and medical potential of these compounds, in particular, with respect to cancer treatment.

Experimental

TLC was performed on POLYGRAM SILG/UV₂₅₄ (Macherey Nagel & Co.). Preparative chromatographic separations were carried out on columns with Merck silica gel 60 (15–40 µm) and Merck precoated silicagel plates 60 F₂₅₄, 20 × 20 cm, 0.25 mm. Melting points (m.p.) were determined on a Bock-Monoskop VS or a Büchi SMP-20 and are uncorrected. Specific optical rotations were determined on a Perkin-Elmer Polarimeter 241 in 1 dm cuvettes at a wavelength of 589 nm. NMR spectra were measured on a Bruker WM 300 spectrometer at 303 K using TMS as an internal reference. The abbreviation of the multiplicities of the shifts is indicated as s for singlet, d for doublet, t for triplet, q for quartet, sxt for sextet, oct for octet, m for multiplet, br for broad, and p for pseudo. Mass spectra were run on a MAT 311 mass spectrometer (Varian). Elemental analyses were performed on a Perkin Elmer 240 Elementar Analyser.

(−)-(4aR,6R,7R,8S,8aS)-7,8-Bis-Benzoyloxy-6-Methyl-8a-Hydroxy-1,4,5-Trioxa-Cis-Decaline (11b)

A mixture of silver carbonate (662 mg, 2.40 mmol), ethylene glycol (134 µL, 149 mg, 2.40 mmol) in water-free dichloromethane (25 mL) was stirred in the presence of a freshly annealed molecular sieve 4 Å (2 g) at room temperature for 15 minutes. 6-Deoxy-ulosyl bromide 10b (867 mg, 2.00 mmol) was then added and stirring continued for 1 hour at room temperature in the dark. Filtration through a pad of kieselguhr and evaporation of the filtrate in vacuo gave a crystalline residue of 787 mg (95 %) of 11b with R _f 0.23 (n-hexane/diethyl ether 1:1). An analytical sample was obtained by flash chromatography on a silica gel column (12 × 2 cm, n-hexane/diethyl ether 10:1 → 1:1) as colorless crystals with m.p. 139°C to 142°C and $[α]_{D}^{20}$ = −80.1 (c = 0.9, CHCl₃).

C₂₂H₂₂O₈ (414.4): calcd. C 63.76, H 5.35; found C 63.85, H 5.31.

MS (FD, 20 mA): m/z = 415 (100%, M + 1).

¹H NMR (300 MHz, CDCl₃) δ 1.38 (d, 3H, 6-CH ₃), 3.57, 4.33 (each 2 H-m, 2H₂, 3H₂), 3.82 (dq, 1 H, 6 H), 4.71 (s, 1 H, 4a H), 5.12 (d, 1 H, 8 H), 5.29 (s, 1 H, OH), 5.51 (dd, 1 H, 7 H), 7.2-8.2 (m, 10 H, 2C₆ H ₅CO). J _6,CH3 = 6.1, J _6,7 = 9.8, J _7,8 = 9.7 Hz.

¹³C NMR (75.5 MHz, CDCl₃) δ 17.5 (CH₃), 59.1, 59.3 (C-2, C-3), 70.0 (C-6), 72.2 (C-7), 79.5 (C-8), 91.1 (C-8a), 95.2 (C-4a), 128-134 (2 C ₆H₅), 165.5, 168.6 (2 C₆H₅ CO).

Diastereomeric mixture of (−)-(2R,3R,4S,5S,10R,S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Hydroxy-1,6,9-Trioxaspiro[4.5]decane (10R,S) (13a)

Aqueous perchloric acid (70 %, 0.8 mL, 9.3 mmol) was added to a stirred solution of the 1,4,5-trioxa-cis-decaline 11a (1.07 g, 2.0 mmol) in dichloromethane (20 mL) with a syringe at 0°C. The mixture was removed from the ice bath and stirred at room temperature. Monitoring of the reaction (TLC) revealed that no appreciable conversion occurred. By refluxing the mixture (40°C), a continuous conversion of 11a to the more polar (10R,S)-13a took place. After a reaction time of 2H a 3:1 equilibrium of product and starting material was achieved. The mixture was diluted with dichloromethane (100 mL) and washed consecutively with water (25 mL), saturated sodium bicarbonate (NaHCO₃) solution (3 × 25 mL) and water (25 mL). Drying (sodium sulfate [Na₂SO₄]) and evaporation to dryness in vacuo left a syrup. The polar byproducts were separated by flash chromatography on a silica gel column (5 × 4 cm, toluene/ethyl acetate 20:1). Again, evaporation of the eluate to dryness in vacuo left a syrup, which was treated with diethyl ether to remove unreacted starting material 11a. After filtration, the mother liquor was evaporated to dryness in vacuo and gave 548 mg (51%) of a 2:5-diastereomeric mixture of (10R,S)-13a as a colorless syrup with R _f 0.24, (toluene/ethyl acetate 4:1) and $[α]_{D}^{20}$ = −64.6 (c = 2.8, CHCl₃).

C₂₉H₂₆O₁₀ (534.5): calcd. C 65.16, H 4.90; found C 65.31, H 5.02.

MS (FD, 20 mA): m/z = 533 (25 %, M⁺ − 1), 412 (100%, M⁺–C₆H₅COOH).

Main (10S)-13a determined from the mixture:

¹H NMR (300 MHz, CDCl₃) δ: 3.47 (dd, 1 H, 8 H_e), 3.84 (m, 2 H, 7 H_a, 7 H_e), 4.10 (m, 1 H, 8 H_a) 4.66 (m, 2 H, 2 H, 2′ H_A), 4.79 (m, 1 H, 2′ H_B), 5.00 (s, 1 H, 10 H, after treatment with D₂O), 5.01 (br s, 1 H, OH), 5.91 (d, 1 H, 4 H), 5.97 (dd, 1 H, 3 H); J _2,3 = 4.4, J _3,4 = 5.9, J _8gem = 11.8, J _7a,8e = 2.1 Hz, all other shifts are overlapped.

¹³C NMR (75.5 MHz, CDCl₃) δ: 60.1 (C-7), 64.7 (CH₂OBz), 65.3 C-8), 76.3/C-4), 77.5 (C-3), 80.1 (C-2), 91.8 (C-10), 102.0 (C-5), 128.0–134.0 (3 C ₆H₅CO), 165.6, 165.8, 166.2 (3 C₆H₅ CO).

Minor (10R)-13a determined from the mixture:

¹H NMR (300 MHz, CDCl₃) δ: 5.02 (s, 1 H, 10 H, after treatment with D₂O), 5.04 (br s, 1 H, OH), 5.83 (d, 1 H, 4 H), 5.87 (dd, 1 H, 3 H); J _2,3 = 3.9, J _3,4 = 5.1 Hz, all other shifts are overlapped.

¹³C NMR (75.5 MHz, CDCl₃) δ: 57.2 (C-8), 61.0 C-7), 64.7 (CH₂OBz), 77.5 (C-4), 77.8 (C-3), 79.7 (C-2), 91.5 (C-10), 100.8 (C-5), 128.0-134.0 (3 C ₆H₅CO), 165.6, 165.8, 166.2 (3 C₆H₅ CO).

(−)-(2R,3R,4S,5S,10S)-10-Acetyloxy-3,4-Bis-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (14b)

Acetic acid anhydride (13.7 mL, 144.8 mmol) and aqueous perchloric acid (70%, 0.5 mL, 5.8 mmol) were added to a stirred solution of the 1,4,5-trioxa-cis-decaline 11b (6.0 g, 15.5 mmol) in dichloromethane (100 mL) with a syringe at 0°C. The mixture was removed from the ice bath and stirred for another 5 minutes. The mixture was then diluted with dichloromethane (200 mL) and washed consecutively with water (2 × 50 mL), saturated NaHCO₃ solution (2 × 50 mL), and water (2 × 50 mL). Drying (Na₂SO₄) and evaporation to dryness in vacuo left a syrup which was purified by flash chromatography on a silica gel column (5 × 5 cm, n-hexane/diethyl ether 1:1). This procedure yielded 6.2 g (94%) of chromatographic uniform 14b (R _f 0.56, toluene/ethyl acetate 4:1) as a colorless syrup which spontaneous crystallized and could be used without additional purification for subsequent reactions. Analytical pure material was obtained by treating with diethyl ether and had m.p. 162°C to 164°C and $[α]_{D}^{20}$ = −207.1 (c = 1.1, CHCl₃).

C₂₄H₂₄O₉ (456.4): calcd. C 63.15, H 5.30; found C 63.20, H 5.29.

MS (FD, 20 mA): m/z = 456 (100%, M⁺).

¹H NMR (300 MHz, CDCl₃) δ: 1.65 (d, 3 H, 2-CH ₃), 1.86 (s, 3 H, CH ₃CO), 3.59 (pdd, 1 H, 7 H_e), 3.74 (pdd, 1 H, 8 H_e), 4.14 (ddd, 1 H, 7 H_a), 4.34 (psxt, 1 H, 2 H), 4.46 (ddd, 1 H, 8 H_a), 5.56 (dd, 1 H, 3 H), 5.83 (d, 1 H, 4 H), 5.93 (s, 1 H, 10 H), 7.3-8.2 (m, 10 H, 2 C₆ H ₅CO); J _2,Me = 6.6, J _2,3 = 5.2, J _3,4 = 6.8, J _7gem = 11.7, J _7a,8a = 12.2, J _7a,8e = 3.0, J _7e,8a = 3.1, J _7e,8e = 0, J _8gem = 11.6 Hz.

¹³C NMR (75.5 MHz, CDCl₃) δ: 20.8 (CH₃CO), 128.0-134.0 (2 C ₆H₅CO), 165.3, 166.0 (2 C₆H₅ CO), 169.4 (CH₃ CO). For all other shifts see Table 3.

(−)-(2R,3R,4S,5S,10S)-3,4,10-Tris-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (15b)

Benzoic acid anhydride (2.72 g, 12.0 mmol) and aqueous perchloric acid (70%, 50 µL, 0.6 mmol) were added to a stirred solution of the 1,4,5-trioxa-cis-decaline 11b (0.50 g, 1.2 mmol) in dichloromethane (10 mL) with a syringe at 0°C. The mixture was removed from the ice bath and stirred for another 5 minutes. The mixture was then diluted with dichloromethane (100 mL) and washed consecutively with water (2 × 25 mL), saturated NaHCO₃ solution (2 × 25 mL), and water (2 × 25 mL). Drying (Na₂SO₄) and evaporation to dryness in vacuo left a syrup which was purified by flash chromatography on a silica gel column (4 × 4 cm, n-hexane/diethyl ether 10:1). Evaporation of the eluate in vacuo to dryness and trituration of the residue with diethyl ether/isopropanol 1:1 gave 0.48 g (77%) of chromatographic uniform 15b as colorless crystals with R _f 0.40, (n-hexane/diethyl ether 1:1), m.p. 108°C to 110°C and $[α]_{D}^{20}$ = −165.0 (c = 1.3, CHCl₃).

C₂₉H₂₆O₉ (518.5): calcd. C 67.17, H 5.05; found C 67.25, H 5.12.

MS (FD, 20 mA): m/z = 518 (100%, M⁺).

¹H NMR (300 MHz, CDCl₃) δ: 1.68 (d, 3 H, 2-CH ₃), 3.64 (pdd, 1 H, 7 H_e), 3.81 (pdd, 1 H, 8 H_e), 4.24 (ddd, 1 H, 7 H_a), 4.37 (psxt, 1 H, 2 H), 4.54 (ddd, 1 H, 8 H_a), 5.58 (dd, 1 H, 3 H), 5.89 (d, 1 H, 4 H), 6.20 (s, 1 H, 10 H), 6.9-8.2 (m, 15 H, 3 C₆ H ₅CO); J _2,Me = 6.5, J _2,3 = 5.2, J _3,4 = 6.8, J _7gem = 11.7, J _7a,8a = 12.2, J _7a,8e = 2.8, J _7e,8a = 2.7, J _7e,8e = 0, J _8gem = 11.6 Hz.

¹³C NMR (75.5 MHz, CDCl₃) δ: 164.5, 164.8, 166.1 (3 C₆H₅ CO). For all other shifts see Table 3.

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Bromo-1,6,9-Trioxaspiro[4.5]decane (16a)

Preparation, physical and spectral data see Cuny et al..⁵⁸

¹³C NMR (75.5 MHz, CDCl₃) δ: 124.2-144.2 (3 C ₆H₅CO) 165.2, 165.6, 166.2 (3 C₆H₅ CO). For all other shifts see Table 3.

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-10-Bromo-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (16b)

(A) Bromination of acetate 14b: A 33% hydrogen bromide solution in glacial acetic acid (5.86 mL, 33.0 mmol) was added to a solution of acetate 14b (500 mg, 1.10 mmol) in dichloromethane (25 mL) and stirred for 10 minutes at room temperature. The mixture was diluted with dichloromethane (200 mL) and washed consecutively with ice water (2 × 50 mL), saturated NaHCO₃ solution (2 × 50 mL), and water (2 × 50 mL). Drying (Na₂SO₄) and evaporation to dryness in vacuo left a syrup which was purified by flash chromatography on a silica gel column (2 × 2 cm, n-hexane/diethyl ether 1:1). Evaporation of the eluate in vacuo to dryness left 390 mg (74%) of chromatographic uniform 16b as colorless syrup with R _f 0.49 (n-hexane/diethyl ether 1:1) and $[α]_{D}^{20}$ = −280.1 (c = 1.1, CHCl₃).

C₂₂H₂₁BrO₇ (477.3): calcd. C 55.36, H 4.22; found C 55.54, H 4.31.

¹H NMR (300 MHz, CDCl₃) δ 1.61 (d, 3 H, 2-CH ₃), 3.70 (pdd, 1 H, 7 H_e), 3.83 (pdd, 1 H, 8 H_e), 4.33 (m, 2 H, 2 H and 7 H_a), 4.50 (ddd, 1 H, 8 H_a), 5.42 (dd, 1 H, 3 H), 5.81 (d, 1 H, 4 H), 6.23 (s, 1 H, 10 H), 7.3-8.2 (m, 10 H, 2 C₆ H ₅CO); J _2,Me = 6.5 J _2,3 = 5.0, J _3,4 = 5.9, J _7gem = 11.7, J _7a,8a = 12.2, J _7a,8e = 3.1, J _7e,8a = 2.9, J _7e,8e = 0, J _8gem = 11.5 Hz.

¹³C NMR (75.5 MHz, CDCl₃) δ: 128.0-134.0 (2 C ₆H₅CO) 165.2, 166.0 (2 C₆H₅ CO). For all other shifts see Table 3.

(B) Bromination of benzoate 15b: The conversion of benzoate 15b (350 mg, 0.68 mmol) with 33% hydrogen bromide solution in glacial acetic acid (3.60 mL, 20.4 mmol) in dichloromethane (25 mL) is analogous to the reaction described in (A) and gave 244 mg (75%) of 16b, the identical product as described above in (A).

(−)-(2R,3R,4S,5R)-3,4-Bis-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (17b)

Azobisisobutyronitrile (AIBN) (25 mg, 0.15 mmol) and tributyltin hydride (350 µL, 1.33 mmol) were successively added to a solution of bromide 16b (195 mg, 0.41 mmol) in toluene (25 mL). The mixture was stirred and refluxed in a nitrogen atmosphere for 0.5 hours. The reaction solution was diluted with acetonitrile (200 mL), washed with n-hexane (3 × 50 mL) and concentrated in vacuo. The remaining syrup of 125 mg (77%) of 17b had R _f 0.34 (n-hexane/diethyl ether 1:1) and after flash column chromatography on silica gel (n-hexane/diethyl ether 1:1) $[α]_{D}^{20}$ = −108.7 (c = 1.3, CHCl₃).

MS (FD, 20 mA): m/z = 398 (80 %, M⁺), 397 (100%, M⁺ − 1).

¹H NMR (300 MHz, CDCl₃) δ: 1.64 (d, 3 H, 2-CH ₃), 3.60-3.80 (m, 3 H, 7 H_e, 8 H_a and 8 H_e), 3,79 (d, 1 H, 10 H_a), 3,85 (d, 1 H, 10-H_e), 4.20-4.40 (m, 2 H, 2 H and 7 H_a), 5.50 (d, 1 H, 4 H), 5.65 (dd, 1 H, 3 H), 7.3-8.2 (m, 10 H, 2 C₆ H ₅CO); J _2,Me = 6.5, J _2,3 = 4.8, J _3,4 = 6.3, J _10gem = 11.8 Hz.

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Methoxy-1,6,9-Trioxaspiro[4.5]decane (18)

Bromide 16a (120 mg, 0.20 mmol) was dissolved in anhydrous methanol (10 mL) followed by the addition of silver carbonate (55 mg, 0.20 mmol) and freshly dried molecular sieve 4 Å (1 g). After the mixture was stirred for 20 minutes at room temperature and under the absence of light, the silver salts were removed by filtration through a pad of kieselguhr and the filter rewashed with dichloromethane. The eluate was evaporated under vacuum to yield 101 mg (92%) of 18 as a syrup with R _f 0.38 (diethyl ether/n-hexane 2:1). An analytical sample was obtained by chromatography on a silica gel column (15 × 2 cm, diethyl ether/n-hexane 2:1) and had $[α]_{D}^{20}$ = −50.3 (c = 0.9, CHCl₃).

C₃₀H₂₈O₁₀ (548.5): calcd. C 65.69, H 5.15; found C 65.48, H 5.06.

MS (FD, 20 mA): m/z = 548 (100 %, M⁺).

¹H NMR (300 MHz, CDCl₃) δ: 3.46 (pdd, 1 H, 7 H_e), 3.68 (s, 3 H, OCH ₃), 3.82 (ddd, 1 H, 8 H_a), 3.88 (pdd, 1 H, 8 H_e), 4.19 (ddd, 1 H, 7 H_a), 4.64 (s, 1 H, 10 H and m, 1 H, 2 H), 4.65 (dd, 1 H, H_A of CH₂OBz), 4.77 (dd, 1 H, H_B of CH₂OBz), 5.91 (d, 1 H, 4 H), 6.02 (dd, 1 H, 3 H), 7.3-8.2 (m, 15 H, 3 C₆ H ₅CO); J _2,HA = 5.4, J _2,HB = 6.3, J _{HA, HB} = 13.6, J _2,3 = 5.2, J _3,4 = 6.8, J _7gem = 11.6, J _7a,8a = 11.4, J _7a,8e = 3.5, J _7e,8a = 2.3, J _7e,8e = 0, J _8gem = 11.8 Hz.

NOE interactions 10 H (4.64) → OCH₃ (3.68), 8 H_a (3.82) and 4 H (5.91 ppm).

¹³C NMR (75.5 MHz, CDCl₃) δ: 57.4 OCH₃), 128.0-134.0 (3 C ₆H₅CO), 165.8, 165.9, 166.2 (3 C₆H₅ CO). For all other shifts see Table 3.

(−)-(2R,3R,4S,5S,10R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Isopropyloxy-1,6,9-Trioxaspiro[4.5]decane (19)

Bromide 16a (140 mg, 0.23 mmol) was dissolved in anhydrous isopropanol (10 mL) followed by the addition of silver carbonate (63 mg, 0.23 mmol) and freshly dried molecular sieve 4 Å (1 g). After the mixture was stirred for 3 hours at room temperature under the absence of light, the silver salts were removed by filtration through a pad of kieselguhr and the filter rewashed with dichloromethane. The filtrate was evaporated under vacuum to yield 118 mg (89%) of 19 as a syrup with R _f 0.43 (diethyl ether/n-hexane 2:1). An analytical sample was obtained by chromatography on a silica gel column (15 × 2 cm, diethyl ether/n-hexane 2:1) and had $[α]_{D}^{20}$ = −45.6 (c = 1.3, CHCl₃).

C₃₀H₂₈O₁₀ (576.6): calcd. C 66.66, H 5.59; found C 66.79, H 5.45.

MS (FD, 20 mA): m/z = 576 (100 %, M⁺).

¹H NMR (300 MHz, CDCl₃) δ: 1.32 (d, 6 H, 2 isopropyl-CH ₃), 3.46 (m, 1 H, 7 H_e), 3.83 (m, 2 H, 8 H_a and 8 H_e), 4.11 (q, 1 H, isopropyl-CH), 4.18 (m, 1 H, 7 H_a), 4.66 (m. 2 H, 2 H and H_A of CH₂OBz), 4.73 (dd, 1 H, H_B of CH₂OBz), 4.81 (s, 1 H, 10 H), 5.84 (d, 1 H, 4 H), 5.97 (dd, 1 H, 3 H), 7.3–8.2 (m, 15 H, 3 C₆ H ₅CO); J _2,HA = 5.0, J _{HA, HB} = 13.6, J _2,3 = 5.1, J _3,4 = 6.0, J _CH,Me = 6.6 Hz, all other shifts are overlapped.

¹³C NMR (75.5 MHz, CDCl₃) isopropyl CH₃: δ: 22.1, 23.6; isopropyl CH 72.8; 128.0–134.0 (3 C ₆H₅CO), 2 × 165.8, 166.2 (3 C₆H₅ CO). For all other shifts see Table 3.

(−)-(2R,3R,4S,5S,10R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Cycolhexyloxy-1,6,9-Trioxaspiro[4.5]decane (20)

Cyclohexanol (170 mg, 180 µL, 1.67 mmol) was dissolved in anhydrous dichloromethane (50 mL) followed by the addition of silver carbonate (460 mg, 1.67 mmol) and freshly dried molecular sieve 4 Å (2 g). After the mixture was stirred for 15 minutes at room temperature under the absence of light, bromide 16a (1.00 g, 1.67 mmol) was added in 1 portion and the mixture heated at reflux for 4 hours under the exclusion of moisture. The silver salts were removed by filtration through a pad of kieselguhr, and the filter was rewashed with dichloromethane. The filtrate was evaporated under vacuum yielding 1.03 g (quant.) of 20 as a syrup with R _f 0.51 (toluene/ethyl acetate 4:1). An analytical sample was obtained by preparative chromatography on a silica gel plate (diethyl ether/n-hexane 1:1) and had $[α]_{D}^{20}$ = −34.8 (c = 0.7, CHCl₃).

C₃₅H₃₆O₁₀ (616.6): calcd. C 68.17, H 5.89; found C 67.65, H 6.01.

MS (FD, 20 mA): m/z = 616 (100 %, M⁺).

¹H NMR (300 MHz, CDCl₃) δ: 0.7-2.4 (m, 10 H, 4 cylohexyl-CH ₂), 3.46 (pdd, 1 H, 7 H_e), 3.78 (m, 1 H, cyclohexyl-CH), 3.83 (m, 2 H, 8 H_a and 8 H_e), 4.19 (m, 1 H, 7 H_a), 4.66 (dd. 2 H, H_A of CH₂OBz), 4.69 (m, 1 H, 2 H), 4.75 (dd, 1 H, H_B of CH₂OBz), 4.89 (s, 1 H, 10 H), 5.85 (d, 1 H, 4 H), 5.97 (dd, 1 H, 3 H), 7.3-8.2 (m, 15 H, 3 C₆ H ₅CO); J _2,HA = 4.8, J _2,HB = 6.4, J _{HA, HB} = 10.4, J _2,3 = 5.1, J _3,4 = 5.6 Hz, all other shifts are overlapped.

NOE interactions 10 H (4.89) → 8 H_a (3.83), 4 H (5.85) and cyclohexyl-CH (3.78 ppm).

¹³C NMR (75.5 MHz, CDCl₃) cyclohexyl CH₂: δ: 24.1, 25.5, 31.8, 39.7; cyclohexyl CH 79.4; 128.0–134.0 (3 C ₆H₅CO), 2 × 165.8, 166.2 (3 C₆H₅ CO). For all other shifts see Table 3.

(+)-(2R,3R,4S,5S,10R,3′R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Cholestanyloxy-1,6,9-Trioxaspiro[4.5]decane (21)

(3β,5α)-Cholestane-3-ol (194 mg, 0.50 mmol) was dissolved in anhydrous dichloromethane (10 mL) followed by the addition of silver carbonate (138 mg, 0.50 mmol) and freshly dried molecular sieve 4 Å (2 g). After the mixture was stirred for 15 minutes at room temperature under the absence of light, bromide 16a (299 mg, 0.50 mmol) was added in 1 portion and the mixture heated at reflux for 45 minutes under the exclusion of moisture. The silver salts were removed by filtration through a pad of kieselguhr and the filter was rewashed with dichloromethane. The filtrate was evaporated under vacuum to yield 387 mg (86%) of 21 as colorless crystals with R _f 0.79 (toluene/ethyl acetate 8:1), melting point 135°C to 136°C and $[α]_{D}^{20}$ = +20.2 (c = 0.9, CHCl₃).

C₅₆H₇₂O₁₀ (905.2): calcd. C 74.31, H 8.02; found C 73.84, H 7.96.

MS (FD, 20 mA): m/z = 904 (100 %, M⁺ − 1).

¹H NMR (300 MHz, CDCl₃) 1,6,9-trioxaspiro[4.5]decane portion δ: 3.45 (pdd, 1 H, 7 H_e), 3.83 (m, 2 H, 8 H_a, and 8 H_e), 4.17 (m, 1 H, 7 H_a), 4.70 (m, 3 H, 2 H, H_A and H_B of CH₂OBz), 4.86 (s, 1 H, 10 H), 5.82 (d, 1 H, 4 H), 5.93 (dd, 1 H, 3 H), 7.2–8.2 (m, 15 H, 3 C₆ H ₅CO); J _2,3 = 4.3, J _3,4 = 5.4 Hz, all other shifts are overlapped.

Main shifts of cholestane portion δ: 0.65 (s, 3 H, 18 H₃), 0.76 (s, 3 H, 19 H₃), 0.86 (2 3H-d, 26 H₃ and 27 H₃), 0.90 (d, 3 H, 21 H₃), 3.73 (m, 1 H, 3 H); J _20,21 = 6.5, J _25,26 = 6.6, J _25,27 = 6.6 Hz.

¹³C NMR (75.5 MHz, CDCl₃) steroidal CH₃: δ 12.1 (C-18), 12.2 (C-19), 18.6 (C-21), 22.6 (C-26), 22.7 (C-27); steroidal CH₂: 21.2, 23.8, 24.2, 28.0, 28.3, 28.7, 29.7, 32.1, 36.2, 36.9, 39.5, 40.0; steroidal CH: 28.0, 35.5, 35.8, 44.9, 54.3, 56.3, 56.5, 79.4; steroidal C: 35.5, 42.6; 128.0–134.0 (3 C ₆H₅CO), 2 × 165.8, 166.2 (3 C₆H₅ CO). For all other shifts see Table 3.

(+)-(2R,3R,4S,5R,10R)-3,4,10-Tris-Benzoyloxy-2-Benzoyloxymethyl-1,6,9-Trioxaspiro[4.5]decane (25) and (+)-1-(2′-Benzoyloxy)-Ethyl-3,4,6-Tri-O-Benzoyl-a-d-Arabino-Hexopyranos-2-ulosid (26)

Benzoic acid anhydride (1.81 g, 8.00 mmol) and perchloric acid (70%) (50 µL, 0.60 mmol) were added to a solution of pyranodioxane 22 (0.30 g, 0.56 mmol) in dichloromethane (10 mL) with a syringe. The mixture was stirred at room temperature for 15 minutes, then diluted with dichloromethane (200 mL), washed successively with water (25 mL), sat. NaHCO₃ solution (3 × 25 mL) and water (25 mL), dried (Na₂SO₄), and evaporated in vacuo.

The remaining residue was filtered through a silica gel column (15 × 2 cm, n-hexane/diethyl ether 3:1) to remove excessive benzoic acid anhydride and polar impurities. The eluate was concentrated in vacuo and the remaining colorless syrup, containing 25 and 26, was chromatographically separated on a silica gel column (15 × 2 cm, n-hexane/diethyl ether 1:2). The eluate with R _f 0.29 gave 219 mg (61%) of 25 as a colorless amorphous solid with $[α]_{D}^{20}$ = +27.8 (c = 0.8, CHCl₃) and with identical physical data as published in Cuny et al..⁵⁸

The fraction with R _f 0.05 (n-hexane/diethyl ether 1:2) afforded 107 mg (30%) of colorless amorphous 26 with $[α]_{D}^{20}$ = +43.2 (c = 0.9, CHCl₃).

C₃₆H₃₀O₁₁ (638.6): calcd. C 67.71, H 4.73; found C 67.56, H 4.62.

MS (FD, 20 mA): m/z = 638 (30 %, M⁺), 517 (100%, M⁺ − 121).

¹H NMR (300 MHz, CDCl₃) δ: 4.04 and 4.21 (each 1 H-m, glycol CH ₂CH₂OBz), 4.45 (dd, 1 H, 6 H_A), 4.61 (m, 3 H, 6-H_B, glycol CH ₂OBz), 4.84 (ddd, 1 H, 5 H), 5.11 (s, 1 H, 1 H), 5.91 (dd, 1 H, 4 H), 6.17 (d, 1 H, 3 H), 7.2–8.2 (m, 20 H, 4 C₆ H ₅CO); J _3,4 = 10.2, J _4,5 = 10.2, J _5,6 = 5.0, J _6A,6B = 12.3 Hz.

¹³C NMR (75.5 MHz, CDCl₃) δ: 62.4 (glycol CH₂OBz), 63.4 (C-6), 66.8 (glycol CH₂CH₂OBz), 68.5 (C-5), 70.5 (C-4), 75.6 (C-3), 99.2 (C-1), 191.4 (C-2), 164.6, 165.1, 166.0, 166.3 (4 C₆H₅ CO).

Footnotes

Acknowledgments

The author thanks Prof Dr M Reggelin for the opportunity to work in his group and Dr V Schmidts for helpful discussions of the ¹H and ¹³C NMR data.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Eckehard Cuny

References

Perron

Albizati

. Chemistry of spiroketals. Chem Rev. 1989;89(7):1617-1661.doi:10.1021/cr00097a015

Brimble

MA.

Farès

. Synthesis of bis-spiroacetal ring systems. Tetrahedron. 1999;55(25):7661-7706.doi:10.1016/S0040-4020(99)00387-7

Brimble

Furkert

. Chemistry of bis-spiroacetal systems: natural products, synthesis and stereochemistry. Curr Org Chem. 2003;7(14):1461-1484.doi:10.2174/1385272033486404

Aho

JE.

Pihko

PM.

Rissa

. Nonanomeric spiroketals in natural products: structures, sources, and synthetic strategies. Chem Rev. 2005;105(12):4406-4440.doi:10.1021/cr050559n

Sperry

Wilson

ZE.

Rathwell

DCK.

Brimble

. Isolation, biological activity and synthesis of benzannulated spiroketal natural products. Nat Prod Rep. 2010;27(8):1117-1137.doi:10.1039/b911514p

Čorić

List

. Asymmetric spiroacetalization catalysed by confined Brønsted acids. Nature. 2012;483(7389):315-319.doi:10.1038/nature10932

Francke

Hindorf

Reith

. Methyl-1,6-dioxaspiro[4.5]decanes as Odors of Paravespula vulgaris (L.). Angew Chem Int Ed Engl. 1978;17(11):862.doi:10.1002/anie.197808621

Iwata

Moritani

Sugiyama

Fujita

Imanishi

. Stereoselective synthesis of all isomers of 2-methyl-1,6-diaxaspiro[4.5]decane (insect pheromone) using a chiral sulfoxide auxiliary. Tetrahedron Lett. 1987;28(20):2255-2258.doi:10.1016/S0040-4039(00)96094-5

Iwata

Moritani

Sugiyama

Izaki

Kuroki

Imanishi

. Synthetic studies on spiroketal natural products. III. Enantioselective synthesis of 1,6-dioxaspiro(4.5)decane compounds. Chem Pharm Bull. 1988;36(12):4785-4793.doi:10.1248/cpb.36.4785

10.

O'Shea

MG.

Kitching

. Organotin and -mercury routes to enones, dienones and spiroacetals. Tetrahedron. 1989;45(4):1177-1186.doi:10.1016/0040-4020(89)80026-2

11.

Rosini

Ballini

Marotta

. Functionalized nitroalkanes in synthesis of 1,6-dioxaspiro[4.5]decane components of Paravespula vulgaris pheromone. Tetrahedron. 1989;45(18):5935-5942.doi:10.1016/S0040-4020(01)89120-1

12.

Cubero

II.

Lopez-Espinosa

MT.

Richardson

. Enantiospecific synthesis from D-fructose of (2S,5R)- and (2R,5R)-2-methyl-1,6-dioxaspiro[4.5]decane [the odor bouquet minor components of Paravespula vulgaris (L.)]. J Chem Ecol. 1993;19(6):1265-1283.doi:10.1007/BF00987385

13.

Zarbin

PHG.

de Oliveira

ARM.

Delay

. Diastereoselective route to (2R,5S)- and (2S,5S)-2-methyl-1,6-dioxaspiro[4.5]decane, a pheromone component of the wasp Paravespula vulgaris . Tetrahedron Lett. 2003;44(36):6849-6851.doi:10.1016/S0040-4039(03)01716-7

14.

Fujioka

Nakahara

Hirose

Hirano

Oki

Kita

. Intramolecular iodoetherification of ene or diene ketals: facile synthesis of spiroketals. Chem Commun. 2011;47(3):1060-1062.doi:10.1039/C0CC03933K

15.

Ledger

PW.

Tanzer

. Monensin - a perturbant of cellular physiology. Trends Biochem Sci. 1984;9(7):313-314.doi:10.1016/0968-0004(84)90299-8

16.

Huczyński

. Polyether ionophores - promising bioactive molecules for cancer therapy. Bioorg Med Chem Lett. 2012;22(23):7002-7010.doi:10.1016/j.bmcl.2012.09.046

17.

Lowicki

Huczyński

. Structure and antimicrobial properties of monensin A and its derivatives: summary of the achievements. Biomed Res Int. 2013;2013:Article ID 742149:14.doi:10.1155/2013/742149

18.

Klejborowska

Maj

Wietrzyk

Stefańska

Huczyński

. One-Pot synthesis and antiproliferative activity of novel double-modified derivatives of the polyether ionophore monensin A. Chem Biol Drug Des. 2018;92(2):1537-1546.doi:10.1111/cbdd.13320

19.

Stierle

AA.

Stierle

DB.

Kelly

. Berkelic acid, a novel spiroketal with selective anticancer activity from an acid mine waste fungal extremophile. J Org Chem. 2006;71(14):5357-5360.doi:10.1021/jo060018d

20.

Buchgraber

Snaddon

TN.

Wirtz

Mynott

Goddard

Fürstner

. A synthesis-driven structure revision of berkelic acid methyl ester. Angew Chem Int Ed Engl. 2008;47(44):8450-8454.doi:10.1002/anie.200803339

21.

Zhou

Snider

. Synthesis of (−)-berkelic acid. Angew Chem Int Ed. 2009;48(7):1283-1286.doi:10.1002/anie.200805488

22.

Fañanás

FJ.

Mendoza

Arto

Temelli

Rodríguez

. Scalable total synthesis of (-)-berkelic acid by using a protecting-group-free strategy. Angew Chem Int Ed Engl. 2012;51(20):4930-4933.doi:10.1002/anie.201109076

23.

McLeod

MC.

Brimble

MA.

Rathwell

DCK.

Wilson

ZE.

Yuen

T-Y

. Synthetic approaches to [5,6]-benzannulated spiroketal natural products. Pure Appl Chem. 2012;84(6):1379-1390.doi:10.1351/PAC-CON-11-08-06

24.

Arto

de Santa-María

IS.

Chiara

M-D.

Fañanás

FJ.

Rodríguez

. Berkelic acid: straightforward analogue synthesis and studies of activity against selected cancer cell lines. European J Org Chem. 2016;2016(35):5876-5880.doi:10.1002/ejoc.201601194

25.

Bender

CF.

Paradise

CL.

Lynch

VM.

Yoshimoto

FK.

De Brabander

. A biosynthetically inspired synthesis of (-)-berkelic acid and analogs. Tetrahedron. 2018;74(9):909-919.doi:10.1016/j.tet.2018.01.021

26.

Williams

DE.

Keyzers

RA.

Warabi

et al. Spirastrellolides C to G: macrolides obtained from the marine sponge Spirastrella coccinea. J Org Chem. 2007;72(25):9842-9845.doi:10.1021/jo7018174

27.

O'Neil

GW.

Ceccon

Benson

Collin

M-P.

Fasching

Fürstner

. Total synthesis of spirastrellolide F methyl ester--part 1: Strategic considerations and revised approach to the southern hemisphere. Angew Chem Int Ed Engl. 2009;48(52):9940-9945.doi:10.1002/anie.200906121

28.

Benson

Collin

M-P.

O'Neil

et al. Total synthesis of spirastrellolide F methyl ester--part 2: Macrocyclization and completion of the synthesis. Angew Chem Int Ed Engl. 2009;48(52):9946-9950.doi:10.1002/anie.200906122

29.

Morris

JC.

Phillips

. Marine natural products: synthetic aspects. Nat Prod Rep. 2011;28(2):269-289.doi:10.1039/c0np00066c

30.

Benson

Collin

M-P.

Arlt

Gabor

Goddard

Fürstner

. Second-generation total synthesis of spirastrellolide F methyl ester: the alkyne route. Angew Chem Int Ed Engl. 2011;50(37):8739-8744.doi:10.1002/anie.201103270

31.

Tánimoto

Gerritz

SW.

Sawabe

Noda

Filla

SA.

Masamune

. The synthesis of naturally occurring (–)-calyculin A. Angew Chem Int Ed Engl.. 1994;33(6):673-675.doi:10.1002/anie.199406731

32.

Fagerholm

AE.

Habrant

Koskinen

AMP

. Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C. Mar Drugs. 2010;8(1):122-172.doi:10.3390/md80100122

33.

Holy

Brautigan

. Calyculin A from Discodermia calyx is a dual action toxin that blocks calcium influx and inhibits protein Ser/Thr phosphatases. Toxins. 2012;4(10):940-954.doi:10.3390/toxins4100940

34.

Wakimoto

Egami

Abe

. Calyculin: nature's way of making the sponge-derived cytotoxin. Nat Prod Rep. 2016;33(6):751-760.doi:10.1039/C5NP00123D

35.

Mitsuhashi

Shima

Kawamura

et al. The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity. Bioorg Med Chem Lett. 1999;9(14):2007-2012.doi:10.1016/S0960-894X(99)00309-1

36.

Uckun

FM.

Mao

Vassilev

AO.

Huang

Jan

. Structure-based design of a novel synthetic spiroketal pyran as a pharmacophore for the marine natural product spongistatin 1. Bioorg Med Chem Lett. 2000;10(6):541-545.doi:10.1016/S0960-894X(00)00044-5

37.

Huang

Mao

Jan

S-T.

Uckun

. Stereocontrolled synthesis of a novel pharmacophore of the tubulin-depolymerizing marine natural product spongistatin. Tetrahedron Lett. 2000;41(11):1699-1702.doi:10.1016/S0040-4039(00)00054-X

38.

Kulkarni

BA.

Roth

GP.

Lobkovsky

Porco

. Combinatorial synthesis of natural product-like molecules using a first-generation spiroketal scaffold. J Comb Chem. 2002;4(1):56-72.doi:10.1021/cc010047w

39.

Cala

Fañanás

FJ.

Rodríguez

. Enantioselective synthesis of spiroacetals: the conquest of a long-sought goal in asymmetric catalysis. Org Biomol Chem. 2014;12(29):5324-5330.doi:10.1039/C4OB00737A

40.

Ramakrishna

Sridhar

. Stereoselective synthesis of 1,6-dioxaspirolactones from spiro-cyclopropanecarboxylated sugars: total synthesis of dihydro-pyrenolide D. RSC Adv. 2015;5(11):8142-8145.doi:10.1039/C4RA16753H

41.

Zinzalla

Milroy

L-G.

Ley

. Chemical variation of natural product-like scaffolds: design and synthesis of spiroketal derivatives. Org Biomol Chem. 2006;4(10):1977-2002.doi:10.1039/b603015g

42.

Zheng

Tice

CM.

Singh

. The use of spirocyclic scaffolds in drug discovery. Bioorg Med Chem Lett. 2014;24(16):3673-3682.doi:10.1016/j.bmcl.2014.06.081

43.

Scheepstra

Andrei

SA.

Unver

et al. Designed spiroketal protein modulation. Angew Chem Int Ed Engl. 2017;56(20):5480-5484.doi:10.1002/anie.201612504

44.

Ponomarev

AA.

Markushina

IA.

Shulyakovskaya

. Synthesis of 2-methoxy-1,6,9-troixaspiro[4.5]dec-3-enes. Chem Het Comp. 1970;6:1077-1080.

45.

Shulyakovskaya

NV.

Vlasova

LV.

Khidekel'

ML.

Markushina

. Hydrogenation of spirocyclic compounds in the presence of homogeneous rhodium catalysts. Russ Chem Bull. 1971;20(8):1689-1690.doi:10.1007/BF00860031

46.

Sawada

Mori

Oku

. Carbon-carbon bond formation reaction of ethereal oxonium ylides via metal-enolate intermediates. J Org Chem. 2003;68(26):10040-10045.doi:10.1021/jo035272+

47.

B-L.

Fan

J-F.

Gao

Y-L

. Molecular diversity from tonghaosu analogues, selective reduction of the endo-cyclic double bond of tonghaosu analogues and the synthesis of cyclopentenone derivatives. Synlett. 2003;3:399-401.

48.

Chen

Yin

B-L.

H-H.

Chiu

M-H.

Y-L

. Study on tonghaosu and its analogs: isolation, structure identification and synthesis of antifeedant B-ring-homo-tonghaosu. Chin J Chem. 2004;22(1):92-99.doi:10.1002/cjoc.20040220120

49.

Ziv

Sava

. Compounds and pharmaceutical compositions comprising same. NST Neurosurvival Technologies Ltd. United States Patent 7:169,940 B1; 2007.

50.

Defaye

Gadelle

Pedersen

. The behaviour of D-fructose and inulin towards anhydrous hydrogen fluoride. Carbohydr Res. 1985;136:53-65.doi:10.1016/0008-6215(85)85185-5

51.

García Fernández

JM.

Gadelle

Defaye

. Difructose dianhydrides from sucrose and fructo-oligosaccharides and their use as building blocks for the preparation of amphiphiles, liquid crystals, and polymers. Carbohydr Res. 1994;265(2):249-269.doi:10.1016/0008-6215(94)00239-8

52.

Ferrier

RJ.

Sankey

. A modified synthesis of 2-hydroxyglycal esters, and their conversion into esters of 2,3-didehydro-3-deoxyaldoses J Chem Soc. 1966:2339-2345.

53.

Rao

DR.

Lerner

. Dehydrohalogenation of glycosyl halides with 1,5-diazabicyclo[5.4.0]undec-5-ene. Carbohydr Res. 1972;22(2):345-350.doi:10.1016/S0008-6215(00)81285-9

54.

Ekborg

Garegg

PJ.

Josephson

. Syntheses of derivatives of p-aminophenyl 3-O-(3,6-dideoxy-α-D-arabino- and α-D-ribo-hexopyranosyl)-α-D-mannopyranosides by use of hydroxyglycal intermediates. Carbohydr Res. 1978;65(2):301-306.doi:10.1016/S0008-6215(00)84325-6

55.

Lichtenthaler

FW.

Cuny

Weprek

. A simple and efficient synthesis for acylated 2-oxoglycosyl bromides from hydroxyglycal esters. Angew Chem. 1983;95(11):906-908.

56.

Lichtenthaler

FW.

Kläres

Lergenmüller

Schwidetzky

. Various glycosyl donors with a ketone or oxime function next to the anomeric centre: facile preparation and evaluation of their selectivities in glycosidations. Synthesis. 1992;1992(1/2):179-184.doi:10.1055/s-1992-34167

57.

Lichtenthaler

FW.

Löhe

Cuny

. Sugar enolones, XIX. An approach to actinospectose-type 2,3-diketo sugars. – synthetic proof for the R configuration of “Herzgift-Methylreduktinsäure”. Liebigs Ann Chem. 1983;1983(11):1973-1985.doi:10.1002/jlac.198319831112

58.

Cuny

Lichtenthaler

FW.

Lindner

. Pyrano[2,3-b]dioxanes through bisacetalic annulation of 2-ketosugars to glycol. European J Org Chem. 2004;2004(23):4901-4910.doi:10.1002/ejoc.200400458

59.

Lemieux

RU.

Nagarajan

. The configuration and conformation of di-d-fructose anhydride I. Can J Chem. 1964;42(6):1270-1278.doi:10.1139/v64-199

Stereoselective Synthesis of 1,6,9-Tri-oxaspiro[4.5]decanes From d -Glucose: Novel Structural Motifs of Spiroacetal Natural Products

Abstract

Keywords

Syntheses

Derivatives with Spiroacetal Motif (R)-7

Derivative with Spiroacetal Motif (S)-7

Structural Elucidation

Furan Portion

1,4-Dioxane Portion

13C NMR Spectral Data

Concluding Remarks

Experimental

(−)-(4aR,6R,7R,8S,8aS)-7,8-Bis-Benzoyloxy-6-Methyl-8a-Hydroxy-1,4,5-Trioxa-Cis-Decaline (11b)

Diastereomeric mixture of (−)-(2R,3R,4S,5S,10R,S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Hydroxy-1,6,9-Trioxaspiro[4.5]decane (10R,S) (13a)

(−)-(2R,3R,4S,5S,10S)-10-Acetyloxy-3,4-Bis-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (14b)

(−)-(2R,3R,4S,5S,10S)-3,4,10-Tris-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (15b)

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Bromo-1,6,9-Trioxaspiro[4.5]decane (16a)

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-10-Bromo-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (16b)

(−)-(2R,3R,4S,5R)-3,4-Bis-Benzoyloxy-2-Methyl-1,6,9-Trioxaspiro[4.5]decane (17b)

(−)-(2R,3R,4S,5S,10S)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Methoxy-1,6,9-Trioxaspiro[4.5]decane (18)

(−)-(2R,3R,4S,5S,10R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Isopropyloxy-1,6,9-Trioxaspiro[4.5]decane (19)

(−)-(2R,3R,4S,5S,10R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Cycolhexyloxy-1,6,9-Trioxaspiro[4.5]decane (20)

(+)-(2R,3R,4S,5S,10R,3′R)-3,4-Bis-Benzoyloxy-2-Benzoyloxymethyl-10-Cholestanyloxy-1,6,9-Trioxaspiro[4.5]decane (21)

(+)-(2R,3R,4S,5R,10R)-3,4,10-Tris-Benzoyloxy-2-Benzoyloxymethyl-1,6,9-Trioxaspiro[4.5]decane (25) and (+)-1-(2′-Benzoyloxy)-Ethyl-3,4,6-Tri-O-Benzoyl-a-d-Arabino-Hexopyranos-2-ulosid (26)

Footnotes

Acknowledgments

Declaration of Conflicting Interests

Funding

ORCID iD

References

¹³C NMR Spectral Data